<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2"><B>As filed with the Securities and Exchange Commission on November 19, 2003</B></FONT>
<DIV align="right"><FONT size="2"><B>Registration No.&nbsp;333-_________</B>
</FONT></DIV>

<HR size="4" noshade>

<P align="center"><FONT size="2"><B>SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549</B>
</FONT>
<HR size="1" noshade width="18%">
<DIV align="center"><FONT size="2"><B>FORM S-8<BR>
REGISTRATION STATEMENT<BR>
Under the Securities Act of 1933</B>
</FONT></DIV>
<HR size="1" noshade width="18%">
<DIV align="center"><FONT size="4"><B>ReGen Biologics, Inc.</B><BR></FONT></DIV>
<DIV align="center"><FONT size="2">(Exact Name of Registrant as Specified in its Charter)</FONT></DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="90%">
<TR valign="bottom">
    <TD width="57%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="38%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Delaware</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
23-2476415</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">(State or Other Jurisdiction of</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
(I.R.S. Employer</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">Incorporation or Organization)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Identification Number)</FONT></TD>
</TR>
</TABLE>
</CENTER>

<HR size="1" noshade width="18%">
<DIV align="center"><FONT size="2"><B>1290 Bay Dale Drive<BR>
PMB 351<BR>
Arnold, MD 21012<BR>
(410)&nbsp;349 &#150; 2431</B><BR>
(Address of Principal Executive Offices)
</FONT></DIV>

<P align="center"><FONT size="2"><B>ReGen Biologics, Inc. Amended and Restated Non-Employee Director Supplemental Stock Option Plan</B><BR>
(Full title of the Plans)
</FONT>

<P align="center"><FONT size="2"><B>Gerald E. Bisbee, Jr., Ph.D.<BR>
CHAIRMAN AND CHIEF EXECUTIVE OFFICER<BR>
ReGen Biologics, Inc.<BR>
1290 Bay Dale Drive<BR>
PMB 351<BR>
Arnold, MD 21012</B><BR>
(Name and Address of agent for service)
</FONT>

<P align="center"><FONT size="2"><B>(410)&nbsp;349 &#150; 2431</B><BR>
(Telephone number, including area code, of agent for service)
</FONT>
<HR size="1" noshade width="43%">
<div align="center"><FONT size="2"><i>Copies to:</i><br>
Andrew M. Tucker, Esq.<br>
Shaw Pittman LLP<br>
1650 Tysons Boulevard<br>
McLean, Virginia 22102<br>
(703)770-7900
</FONT></div>


<P align="center"><FONT size="2"><B>CALCULATION OF REGISTRATION FEE</B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="90%">
<TR valign="bottom">
    <TD width="28%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed Maximum</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed Maximum</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Title of securities</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Amount to be</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Offering Price Per</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Aggregate Offering</B></FONT></TD>
    <TD nowrap align="center" colspan="2"><FONT size="1"><B>Amount of</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>to be registered</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Registered</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Share</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Price</B></FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Registration Fee</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Common Stock $0.01<BR>
par value</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
<B>250,000 (1)</B>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2"><B>$1.21(2)</B>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD colspan="3" align="center" valign="top"><FONT size="2"><B>$302,500</B>
</FONT></TD>
    <TD colspan="2" align="center" valign="top"><FONT size="2"><B>$24.47</B></FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount represents the number of shares issuable pursuant to the Amended
and Restated Non-Employee Director Supplemental Stock Option Plan of ReGen
Biologics, Inc. in addition to the 120,000 shares registered on Registration
Statement No.&nbsp;333-88747 and the 130,000 shares registered on Registration
Statement No.&nbsp;333-44088. This Registration Statement shall also cover any
additional shares of common stock which may become issuable by reason of any
stock dividend, stock split, recapitalization or other similar transactions in
accordance with Rule&nbsp;416 under the Securities Act of 1933, as amended.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Estimated solely for the purpose of calculating the registration fee,
and based upon the high and low prices price per share of the Registrant&#146;s
Common Stock on the OTCBB as of November&nbsp;12, 2003 in accordance with Rule
457(h) of the Securities Act of 1933, as amended.
</FONT>
<P align="center"><FONT size="2">2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="left"><FONT size="2"><B>PART I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by Part I is included in documents sent or given
to participants in the Amended and Restated Non-Employee Director Stock Option
Plan of ReGen Biologics, Inc., a Delaware corporation (the &#147;Registrant&#148;),
pursuant to Rule&nbsp;428(b)(1) under the Securities Act of 1933, as amended (the
&#147;Securities Act&#148;).
</FONT>
<P align="left"><FONT size="2"><B>PART II.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Item&nbsp;3.&nbsp;&nbsp;&nbsp; Incorporation of Documents by Reference.</b>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Registrant is subject to the informational and reporting requirements
of Sections&nbsp;13(a), 14 and 15(d) of the Securities Exchange Act of 1934, as
amended (the &#147;Exchange Act&#148;), and in accordance therewith files reports, proxy
statements and other information with the Securities and Exchange Commission.
The following documents, which are on file with the Securities and Exchange
Commission, are incorporated in this Registration Statement by reference:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="10%"></TD>
        <TD width="5%"></TD>
        <TD width="85%"></TD>
</TR>
<TR valign="top">
        <TD align="center"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center"><FONT size="2">(a)</FONT></TD>
        <TD><FONT size="2">The Registrant&#146;s latest annual report
filed pursuant to Section&nbsp;13(a) of the Exchange Act,
that contains audited financial statements for the
Registrant&#146;s latest fiscal year for which such
statements have been filed;</FONT></TD>
</TR>

</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="10%"></TD>
        <TD width="5%"></TD>
        <TD width="85%"></TD>
</TR>
<TR valign="top">
        <TD align="center"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center"><FONT size="2">(b)</FONT></TD>
        <TD><FONT size="2">All other reports filed pursuant to
Section&nbsp;13(a) or 15(d) of the Exchange Act since the end
of the fiscal year covered by the document referred to
in (a)&nbsp;above.</FONT></TD>
</TR>

</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="10%"></TD>
        <TD width="5%"></TD>
        <TD width="85%"></TD>
</TR>
<TR valign="top">
        <TD align="center"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center"><FONT size="2">(c)</FONT></TD>
        <TD><FONT size="2">The description of the common stock
of the Registrant, $0.0l par value per share (the
&#147;Common Stock&#148;), which is contained in a registration
statement on Form&nbsp;8-A filed under the Exchange Act on
June&nbsp;4, 1996, including any amendment or report filed
for the purpose of updating such description.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All documents subsequently filed by the Registrant pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a
post-effective amendment which indicates that all shares offered hereby have
been sold or which deregisters all shares then remaining unsold, shall be
deemed to be incorporated in this Registration Statement by reference and to be
a part hereof from the date of filing of such documents. Any statement
contained in a document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for the purposes of this
Registration Statement to the extent a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or
superseded, to constitute a part of this Registration Statement.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Item&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Description of Securities.</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Item&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interests of Named Experts and Counsel.</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Item&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indemnification of Directors and Officers.</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our charter includes provisions that eliminate the personal liability of
our directors for monetary damages for breach of fiduciary duty as a director,
except for liability:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="3%" align="left" nowrap><FONT size="2">&#149;</FONT></TD>
        <TD width="94%"><FONT size="2">for any breach of the director&#146;s duty of loyalty to the
Company or its stockholders;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="3%" align="left" nowrap><FONT size="2">&#149;</FONT></TD>
        <TD width="94%"><FONT size="2">for acts or omissions not in good faith or that involved
intentional misconduct or a knowing violation of law;</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="3%" align="left" nowrap><FONT size="2">&#149;</FONT></TD>
        <TD width="94%"><FONT size="2">under Section&nbsp;174 of the Delaware General Corporation law; or</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="3%" align="left" nowrap><FONT size="2">&#149;</FONT></TD>
        <TD width="94%"><FONT size="2">for any transaction from which the director derives an improper personal benefit.</FONT></TD>
</TR>
</TABLE>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our charter requires, as a condition to advancing expenses, the delivery
to the corporation of an undertaking by or on behalf of such director or
officer to repay all amounts so advanced if it shall ultimately be determined
that such director or officer is not entitled to be indemnified.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our charter further provides for the indemnification of our directors and
officers to the fullest extent permitted by Section&nbsp;145 of the Delaware General
Corporation Law. Indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Company under the foregoing provisions, or otherwise. We have been advised
that in the opinion of the Securities and Exchange Commission indemnification
for liabilities arising under the Securities Act may be against public policy
as expressed in the Securities Act and in such an event would be unenforceable.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our officers and directors are also indemnified pursuant to the
Registration Rights Agreements entered into as of September&nbsp;23, 2003 and
September&nbsp;30, 2003 by and among the Company, each of the holders of the Series
A Convertible Preferred Stock and each of the holders of the Series&nbsp;C
Convertible Preferred Stock. These agreements provide for indemnification of
officers and directors for losses, claims, damages, or liabilities incurred by
these people arising out of his or her services as an officer or director or at
our request.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Item&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exemption from Registration Claimed.</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Item&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Exhibit&nbsp;Index immediately preceding the exhibits is attached hereto
and incorporated herein by reference.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Item&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Undertakings.</B>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Registrant hereby
undertakes:</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="10%"></TD>
        <TD width="5%"></TD>
        <TD width="85%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center"><FONT size="2">(a)</FONT></TD>
        <TD><FONT size="2">To file, during any period in which
offers or sales are being made, a post-effective
amendment to this Registration Statement to include any
material information with respect to the plan of
distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement.</FONT></TD>
</TR>

</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="10%"></TD>
        <TD width="5%"></TD>
        <TD width="85%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center"><FONT size="2">(b)</FONT></TD>
        <TD><FONT size="2">That, for the purpose of determining
any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new
registration statement relating to the securities
offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide
offering thereof.</FONT></TD>
</TR>

</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="10%"></TD>
        <TD width="5%"></TD>
        <TD width="85%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center"><FONT size="2">(c)</FONT></TD>
        <TD><FONT size="2">&nbsp;To remove from registration by means
of a post-effective amendment any of the securities
being registered which remain unsold at the termination
of the offering.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant&#146;s annual report pursuant to Section&nbsp;13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Securities Exchange Act
of 1934) that is incorporated by reference in the</FONT>
<P align="center"><FONT size="2">3</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P><FONT size="2">registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.
</FONT>
<P align="center"><FONT size="2">4</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form&nbsp;S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Arnold, Maryland on the 19th day of November, 2003.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
ReGen Biologics, Inc.<BR><BR>
By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  /s/  Gerald E. Bisbee, Jr., Ph.D.<BR>
</FONT><HR size="1" noshade><FONT size="2">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gerald E. Bisbee, Jr., Ph.D.<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chairman and Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2"><B>POWER OF ATTORNEY</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We, the undersigned officers and directors of ReGen Biologics, Inc. hereby
severally constitute Gerald E. Bisbee, Jr., Ph.D. and Brion Umidi, and each of
them singly, our true and lawful attorneys with full power to them, and each of
them singly, to sign for us and in our names in the capacities indicated below
the Registration Statement on Form&nbsp;S-8 filed herewith and any and all
subsequent amendments to said Registration Statement, and generally to do all
such things in our names and behalf in our capacities as officers and directors
to enable ReGen Biologics, Inc. to comply with all requirements of the
Securities and Exchange Commission, hereby ratifying and confirming our
signatures as they may be signed by said attorneys, or any of them, to said
Registration Statement and any and all amendments thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed below by the following persons in the capacities and
on the dates indicated.
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left"><FONT size="1"><B>Signature</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="left"><FONT size="1"><B>Title</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="left"><FONT size="1"><B>Date</B></FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ Gerald E. Bisbee, Jr., Ph.D.
<HR size="1" noshade>
Gerald E. Bisbee, Jr., Ph.D.</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Chairman, President and Chief<BR>
Executive Officer
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November 19, 2003</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ Brion Umidi
<HR size="1" noshade>
Brion Umidi</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Senior Vice President, Chief<BR>
Financial Officer and Chief<BR>
Accounting Officer
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November 19, 2003</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ Alan W. Baldwin
<HR size="1" noshade>
Alan W. Baldwin</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November 19, 2003</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ Richard Fritschi
<HR size="1" noshade>
Richard Fritschi</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November 19, 2003</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
    <TD valign="top"><FONT size="2">/s/ Robert G. McNeil, Ph.D.
<HR size="1" noshade>
Robert G. McNeil, Ph.D.</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November&nbsp;19, 2003</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ J. Richard Steadman, M.D.
<HR size="1" noshade>
J. Richard Steadman, M.D.</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November 13, 2003</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR>
    <TD valign="top"><FONT size="2">/s/ Abhi Acharya
<HR size="1" noshade>
Abhi Acharya</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">November 13, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P align="center"><FONT size="2">5</FONT>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<P align="center"><FONT size="2"><B>EXHIBIT INDEX</B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left"><FONT size="1"><B><u>Exhibit</u></B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="left"><FONT size="1"><B><u>Number</u></B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="left"><FONT size="1"><B><u>Description</u></B></FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">3.1*</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Amended and Restated Certificate of Incorporation of the Registrant</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">3.2**</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Certificate of Amendment to the Certificate of Incorporation</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">3.3***</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Certificate of Ownership and Merger</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">3.4****</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Amended and Restated By-Laws of the Registrant</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">3.5*****</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Description of the common stock of the Registrant</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">5.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Opinion of Shaw Pittman LLP, counsel to the Registrant</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of Ernst &#038; Young LLP</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of Shaw Pittman LLP, counsel to the Registrant (included in Exhibit&nbsp;5.1)</FONT></TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">24.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Power of Attorney (included on the signature page of this Registration Statement)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">*</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated herein by reference from Exhibits to the Registrant&#146;s Report
on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 1997 (File No.&nbsp;0-20805)</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">**</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated herein by reference from Exhibits to the Registrant&#146;s Report
on Form&nbsp;10-Q for the quarter ended June&nbsp;30, 2001 (File No.&nbsp;0-20805)</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">***</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated herein by reference from Exhibits to the Registrant&#146;s
Current Report on Form&nbsp;8-K dated January&nbsp;6, 2003 (File No.&nbsp;0-20805)</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">****</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated herein by reference from Exhibits to the Registrant&#146;s Report
on Form&nbsp;10-K for the year ended December&nbsp;31, 2000 (File No.&nbsp;0-20805)</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">*****</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Incorporated herein by reference from the Registrant&#146;s Registration
Statement on Form&nbsp;8-A filed on June&nbsp;4, 1996 (File No.&nbsp;0-20805), including
any amendment or report filed for the purpose of updating such description</FONT></TD>
</TR>
</TABLE>

<P align="center"><FONT size="2">6</FONT>




</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "w91818asv8.htm", "description": "REGISTRATION STATEMENT, FORM S-8", "secsgml_size_bytes": 31763}]
{"company-data": {"conformed-name": "REGEN BIOLOGICS INC", "cik": "0000883697", "assigned-sic": "3841", "irs-number": "232476415", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-110606", "film-number": "031013784"}, "business-address": {"street1": "1650 TYSONS BLVD", "city": "MCLEAN", "state": "VA", "zip": "22102", "phone": "7038471400"}, "mail-address": {"street1": "1650 TYSONS BLVD", "city": "MCLEAN", "state": "VA", "zip": "22102"}, "former-company": [{"former-conformed-name": "AROS CORP", "date-changed": "20010712"}, {"former-conformed-name": "APACHE MEDICAL SYSTEMS INC", "date-changed": "19960426"}]}
sv8
As filed with the Securities and Exchange Commission on November 19, 2003
Registration No. 333-_________
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under the Securities Act of 1933
ReGen Biologics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
23-2476415
(State or Other Jurisdiction of
(I.R.S. Employer
Incorporation or Organization)
Identification Number)
1290 Bay Dale Drive
PMB 351
Arnold, MD 21012
(410) 349 – 2431
(Address of Principal Executive Offices)
ReGen Biologics, Inc. Amended and Restated Non-Employee Director Supplemental Stock Option Plan
(Full title of the Plans)
Gerald E. Bisbee, Jr., Ph.D.
CHAIRMAN AND CHIEF EXECUTIVE OFFICER
ReGen Biologics, Inc.
1290 Bay Dale Drive
PMB 351
Arnold, MD 21012
(Name and Address of agent for service)
(410) 349 – 2431
(Telephone number, including area code, of agent for service)
Copies to:
Andrew M. Tucker, Esq.
Shaw Pittman LLP
1650 Tysons Boulevard
McLean, Virginia 22102
(703)770-7900
CALCULATION OF REGISTRATION FEE
Proposed Maximum
Proposed Maximum
Title of securities
Amount to be
Offering Price Per
Aggregate Offering
Amount of
to be registered
Registered
Share
Price
Registration Fee
Common Stock $0.01
par value
250,000 (1)
$1.21(2)
$302,500
$24.47
1.     Amount represents the number of shares issuable pursuant to the Amended
and Restated Non-Employee Director Supplemental Stock Option Plan of ReGen
Biologics, Inc. in addition to the 120,000 shares registered on Registration
Statement No. 333-88747 and the 130,000 shares registered on Registration
Statement No. 333-44088. This Registration Statement shall also cover any
additional shares of common stock which may become issuable by reason of any
stock dividend, stock split, recapitalization or other similar transactions in
accordance with Rule 416 under the Securities Act of 1933, as amended.
2. Estimated solely for the purpose of calculating the registration fee,
and based upon the high and low prices price per share of the Registrant's
Common Stock on the OTCBB as of November 12, 2003 in accordance with Rule
457(h) of the Securities Act of 1933, as amended.
2
PART I.       INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information required by Part I is included in documents sent or given
to participants in the Amended and Restated Non-Employee Director Stock Option
Plan of ReGen Biologics, Inc., a Delaware corporation (the "Registrant"),
pursuant to Rule 428(b)(1) under the Securities Act of 1933, as amended (the
"Securities Act").
PART II.      INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.    Incorporation of Documents by Reference.
The Registrant is subject to the informational and reporting requirements
of Sections 13(a), 14 and 15(d) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and in accordance therewith files reports, proxy
statements and other information with the Securities and Exchange Commission.
The following documents, which are on file with the Securities and Exchange
Commission, are incorporated in this Registration Statement by reference:
(a)
The Registrant's latest annual report
filed pursuant to Section 13(a) of the Exchange Act,
that contains audited financial statements for the
Registrant's latest fiscal year for which such
statements have been filed;
(b)
All other reports filed pursuant to
Section 13(a) or 15(d) of the Exchange Act since the end
of the fiscal year covered by the document referred to
in (a) above.
(c)
The description of the common stock
of the Registrant, $0.0l par value per share (the
"Common Stock"), which is contained in a registration
statement on Form 8-A filed under the Exchange Act on
June 4, 1996, including any amendment or report filed
for the purpose of updating such description.
All documents subsequently filed by the Registrant pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a
post-effective amendment which indicates that all shares offered hereby have
been sold or which deregisters all shares then remaining unsold, shall be
deemed to be incorporated in this Registration Statement by reference and to be
a part hereof from the date of filing of such documents. Any statement
contained in a document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for the purposes of this
Registration Statement to the extent a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or
superseded, to constitute a part of this Registration Statement.
Item 4.      Description of Securities.
Not Applicable.
Item 5.      Interests of Named Experts and Counsel.
Not Applicable.
Item 6.      Indemnification of Directors and Officers.
Our charter includes provisions that eliminate the personal liability of
our directors for monetary damages for breach of fiduciary duty as a director,
except for liability:
•
for any breach of the director's duty of loyalty to the
Company or its stockholders;
•
for acts or omissions not in good faith or that involved
intentional misconduct or a knowing violation of law;
2
•
under Section 174 of the Delaware General Corporation law; or
•
for any transaction from which the director derives an improper personal benefit.
Our charter requires, as a condition to advancing expenses, the delivery
to the corporation of an undertaking by or on behalf of such director or
officer to repay all amounts so advanced if it shall ultimately be determined
that such director or officer is not entitled to be indemnified.
Our charter further provides for the indemnification of our directors and
officers to the fullest extent permitted by Section 145 of the Delaware General
Corporation Law. Indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Company under the foregoing provisions, or otherwise. We have been advised
that in the opinion of the Securities and Exchange Commission indemnification
for liabilities arising under the Securities Act may be against public policy
as expressed in the Securities Act and in such an event would be unenforceable.
Our officers and directors are also indemnified pursuant to the
Registration Rights Agreements entered into as of September 23, 2003 and
September 30, 2003 by and among the Company, each of the holders of the Series
A Convertible Preferred Stock and each of the holders of the Series C
Convertible Preferred Stock. These agreements provide for indemnification of
officers and directors for losses, claims, damages, or liabilities incurred by
these people arising out of his or her services as an officer or director or at
our request.
Item 7.      Exemption from Registration Claimed.
Not applicable.
Item 8.      Exhibits.
The Exhibit Index immediately preceding the exhibits is attached hereto
and incorporated herein by reference.
Item 9.      Undertakings.
1.     The Registrant hereby
undertakes:
(a)
To file, during any period in which
offers or sales are being made, a post-effective
amendment to this Registration Statement to include any
material information with respect to the plan of
distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement.
(b)
That, for the purpose of determining
any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new
registration statement relating to the securities
offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide
offering thereof.
(c)
To remove from registration by means
of a post-effective amendment any of the securities
being registered which remain unsold at the termination
of the offering.
2.     The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act
of 1934) that is incorporated by reference in the
3
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
3.     Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.
4
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Arnold, Maryland on the 19th day of November, 2003.
ReGen Biologics, Inc.
By:        /s/  Gerald E. Bisbee, Jr., Ph.D.
Gerald E. Bisbee, Jr., Ph.D.
Chairman and Chief Executive Officer
POWER OF ATTORNEY
We, the undersigned officers and directors of ReGen Biologics, Inc. hereby
severally constitute Gerald E. Bisbee, Jr., Ph.D. and Brion Umidi, and each of
them singly, our true and lawful attorneys with full power to them, and each of
them singly, to sign for us and in our names in the capacities indicated below
the Registration Statement on Form S-8 filed herewith and any and all
subsequent amendments to said Registration Statement, and generally to do all
such things in our names and behalf in our capacities as officers and directors
to enable ReGen Biologics, Inc. to comply with all requirements of the
Securities and Exchange Commission, hereby ratifying and confirming our
signatures as they may be signed by said attorneys, or any of them, to said
Registration Statement and any and all amendments thereto.
Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed below by the following persons in the capacities and
on the dates indicated.
Signature
Title
Date
/s/ Gerald E. Bisbee, Jr., Ph.D.
Gerald E. Bisbee, Jr., Ph.D.
Chairman, President and Chief
Executive Officer
November 19, 2003
/s/ Brion Umidi
Brion Umidi
Senior Vice President, Chief
Financial Officer and Chief
Accounting Officer
November 19, 2003
/s/ Alan W. Baldwin
Alan W. Baldwin
Director
November 19, 2003
/s/ Richard Fritschi
Richard Fritschi
Director
November 19, 2003
/s/ Robert G. McNeil, Ph.D.
Robert G. McNeil, Ph.D.
Director
November 19, 2003
/s/ J. Richard Steadman, M.D.
J. Richard Steadman, M.D.
Director
November 13, 2003
/s/ Abhi Acharya
Abhi Acharya
Director
November 13, 2003
5
EXHIBIT INDEX
Exhibit
Number
Description
3.1*
Amended and Restated Certificate of Incorporation of the Registrant
3.2**
Certificate of Amendment to the Certificate of Incorporation
3.3***
Certificate of Ownership and Merger
3.4****
Amended and Restated By-Laws of the Registrant
3.5*****
Description of the common stock of the Registrant
5.1
Opinion of Shaw Pittman LLP, counsel to the Registrant
23.1
Consent of Ernst & Young LLP
23.2
Consent of Shaw Pittman LLP, counsel to the Registrant (included in Exhibit 5.1)
24.1
Power of Attorney (included on the signature page of this Registration Statement)
*
Incorporated herein by reference from Exhibits to the Registrant's Report
on Form 10-Q for the quarter ended June 30, 1997 (File No. 0-20805)
**
Incorporated herein by reference from Exhibits to the Registrant's Report
on Form 10-Q for the quarter ended June 30, 2001 (File No. 0-20805)
***
Incorporated herein by reference from Exhibits to the Registrant's
Current Report on Form 8-K dated January 6, 2003 (File No. 0-20805)
****
Incorporated herein by reference from Exhibits to the Registrant's Report
on Form 10-K for the year ended December 31, 2000 (File No. 0-20805)
*****
Incorporated herein by reference from the Registrant's Registration
Statement on Form 8-A filed on June 4, 1996 (File No. 0-20805), including
any amendment or report filed for the purpose of updating such description
6